Kennedy Capital Management, Inc. Reata Pharmaceuticals Inc Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $607,441 - $1.15 Million	-27,424 Reduced 37.54%	45,626 $1.73 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $109,297 - $205,475	-5,631 Reduced 7.16%	73,050 $1.84 Million
Q2 2022 Aug 10, 2022	SELL	$20.71 - $36.5 $18,597 - $32,777	-898 Reduced 1.13%	78,681 $2.39 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $1,326 - $2,178	55 Added 0.07%	79,579 $2.61 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $233,486 - $1.01 Million	9,117 Added 12.95%	79,524 $2.1 Million
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $88,300 - $126,286	-883 Reduced 1.24%	70,407 $7.08 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $261,343 - $505,157	-3,339 Reduced 4.47%	71,290 $10.1 Million
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $247,406 - $348,626	2,625 Added 3.65%	74,629 $7.44 Million
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $80,399 - $145,480	-788 Reduced 1.08%	72,004 $8.9 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $61,355 - $107,151	-656 Reduced 0.89%	72,792 $7.09 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $132,993 - $185,917	-1,053 Reduced 1.41%	73,448 $11.5 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $177,672 - $354,515	-1,431 Reduced 1.88%	74,501 $10.8 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $6.67 Million - $19.5 Million	-89,382 Reduced 54.07%	75,932 $15.5 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $1.85 Million - $2.48 Million	-25,895 Reduced 13.54%	165,314 $13.3 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $353,392 - $429,009	-4,547 Reduced 2.32%	191,209 $18 Million
Q1 2019 May 13, 2019	SELL	$51.9 - $101.79 $921,692 - $1.81 Million	-17,759 Reduced 8.32%	195,756 $16.7 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $76.44 $2.99 Million - $4.68 Million	-61,257 Reduced 22.29%	213,515 $12 Million
Q3 2018 Nov 14, 2018	SELL	$35.64 - $92.06 $1.71 Million - $4.42 Million	-48,029 Reduced 14.88%	274,772 $22.5 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $1.68 Million - $3.46 Million	84,491 Added 35.45%	322,801 $11.3 Million
Q1 2018 May 14, 2018	SELL	$20.0 - $30.19 $229,920 - $347,064	-11,496 Reduced 4.6%	238,310 $4.89 Million
Q4 2017 Feb 13, 2018	BUY	$22.39 - $33.27 $1.02 Million - $1.52 Million	45,546 Added 22.3%	249,806 $7.08 Million
Q3 2017 Nov 13, 2017	BUY	$26.29 - $31.88 $5.37 Million - $6.51 Million	204,260	204,260 $6.35 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account